Subcutaneous Drug Delivery Market

Subcutaneous Drug Delivery Market - Global
Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Subcutaneous drug delivery route has emerged as a promising and viable alternative to
intravenous administration. The demand for subcutaneous delivery route is attributed to the
rapid development of biologics in fastest growing sector of the pharmaceutical industry.
Moreover, the subcutaneous route of administration is generally preferred, as it enables selfmedication, improves quality of life, and thus reduce health care costs.
Get Sample Copy At:
Furthermore, convenience and safety for both patients and medical professionals offered by
subcutaneous devices are major factors leading to growth of the global subcutaneous drug
delivery market. According to World Health Organization, 2014, around 2 million healthcare
professionals suffered from infectious diseases as result of needlestick injuries globally. The
retractable nature of prefilled syringes help to overcome this problem acting as an ideal device
to reduce the occurrence of needlestick injuries.
The global subcutaneous drug delivery market size was valued at US$ 7,077.5 million in 2017
and is expected to exhibit a CAGR of 9.5% over the forecast period (2018–2026).
Report includes chapters which deeply display the following deliverable about industry :
• Subcutaneous Drug Delivery Market Research Objective and Assumption
• Subcutaneous Drug Delivery Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Subcutaneous Drug Delivery Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Subcutaneous Drug Delivery Market , By Regions
• Subcutaneous Drug Delivery Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Subcutaneous Drug Delivery Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Subcutaneous Drug Delivery Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Subcutaneous Drug Delivery Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Increasing prevalence of arthritis, multiple sclerosis, and diabetes to propel the global
subcutaneous drug delivery market growth.
Increasing prevalence of multiple sclerosis (MS), rheumatoid arthritis, diabetes, and food
allergies is expected to drive growth of the global subcutaneous drug delivery market, as most
of the drugs are administered through subcutaneous drug delivery route. According to the study
by National Multiple Sclerosis Society, 2017, an estimated 1 million people in the U.S. are
living with MS, where around 200 new cases are diagnosed each week in the U.S.
According to the Multiple Sclerosis Trust, 2018, an estimated 2,500,000 people in the world
have multiple sclerosis. According to the Arthritis Foundation, 2017, around 41 people were
diagnosed with Rheumatoid arthritis (RA) out of every 100,000 people in the U.S. The
foundation further states that about 1.3 million Americans have RA.
According to the Indian
population suffering from
combined. The foundation
suffering from diabetes in
Diabetes Research Foundation, 2016, around 60% of the world’s
diabetes lives in Asia, with around one-half in China and India
also states that Western Pacific reported over 138.2 million people
2015, the number for which is expected to rise to 201.8 million by
Prevention of needlestick injuries to bolster the market growth.
Increasing awareness regarding safety and concern of needlestick injuries is a major factor
driving growth of the global subcutaneous drug delivery market. According to the Health
Protection Agency (HPA) report, in 2012, injuries among medical and dental professionals while
treating patients increased by 131% (100-231) from 2002 to 2011.
Moreover, preference for safety injection devices is increasing among healthcare professionals
and manufacturers, as these devices decrease chances of needlestick injuries. For instance, the
WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to
prevent needlestick injuries. Moreover, in May 2017, Innovative Neurons LLC announced to
commercialize its patented auto retractable multi-needle syringe known as FAST (fast,
accessible, safe, and technology) to decrease needlestick injuries.
Browse Complete Report For More Information @
Key Players
Major players operating in the global subcutaneous drug delivery market include Becton
Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis
International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG,
Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Subcutaneous drug delivery route has emerged as a promising and viable alternative to intravenous administration.